24 research outputs found
Diferencias entre los métodos de determinación de 2.a y 3.a generación de la parathormona sérica sobre la mortalidad en el paciente en hemodiálisis
Parathormone plays a key role in controlling mineral metabolism. PTH is considered a uremic
toxin causing cardiovascular damage and cardiovascular mortality in dialysis patients.
There are two different assays to measure PTH called 2nd generation or intact PTH (iPTH)
and 3rd generation or bioPTH (PTHbio).
Objective: To evaluate the differences in mortality of dialysis patients between both assays
to measure PTH, as well as the possible prognostic role of the PTHbio/iPTH ratio.
Methods: 145 haemodialysis patients were included with 2-year monitoring including baseline
laboratory test and annually thereafter.
Results: 21 patients died in the first year and 28 in the second. No correlation was found
between PTH, PTHbio and PTHbio/iPTH ratio with mortality. Both PTH have a perfect correlation
between them and correlate similarly with other molecules of the mineral metabolism.
The extreme baseline values of PTH are those of higher mortality. In survival by iPTH intervals
(according to guidelines and COSMOS study), a J curve is observed. When iPTH increases,
the ratio decreases, possibly when increasing fragments no. 1–84. There is no greater
prognostic approximation on mortality with PTHbio than PTHi. There was also no difference
in mortality when progression ratio PTHbio/PTHi was analysed.
Conclusions: We didn’t find any advantages to using bioPTH vs. PTHi as a marker of mortality.
BioPTH limits of normality must be reevaluated because its relationship with iPTH is not
consistent. Not knowing these limits affects its prognostic valueLa paratohormona tiene un papel fundamental en el control del metabolismo mineral.
Además es considerada como una toxina urémica al originar dan˜ o cardiovascular e influir
en la mortalidad cardiovascular del paciente en diálisis. Existen dos métodos de medición
denominados de 2.a generación o PTH intacta (PTHi) y de 3.a generación o bioPTH (PTHbio).
Objetivo: Evaluar las diferencias en la mortalidad del paciente en diálisis entre ambas formas
de medición de PTH, así como el posible papel pronóstico de su cociente.
Métodos: Se incluyeron 145 pacientes en hemodiálisis con un seguimiento de 2 an˜ os con
determinación analítica basal y posteriormente de forma anual.
Resultados: Veintiún pacientes fallecieron el primer an˜ o y 28 el segundo. No se encontró
correlación entre PTHi, PTHbio y cociente PTHbio/PTHi con la mortalidad. Ambas PTH tienen
una buena correlación entre ellas y correlacionan de manera similar con otras moléculas del
metabolismo mineral. Los valores basales de PTH extremos son los de mayor mortalidad.
En la supervivencia por tramos de PTHi (según guías y estudio COSMOS) se observa una
curva en J. A mayor aumento de PTHi el cociente desciende, posiblemente al aumentar los
fragmentos no 1-84. No existe una mayor aproximación pronóstica sobre mortalidad con
PTHbio que con PTHi. No se observan diferencias en el valor predictivo del cociente sobre la
mortalidad. Tampoco hubo diferencias en mortalidad cuando se analiza la progresión del
cociente PTHbio/PTHi.
Conclusiones: No encontramos ventajas en la utilización de PTHbio sobre la PTHi como marcador
de mortalidad. Se deben reevaluar los límites de la PTHbio pues su relación con la
PTHi no es constante. El no conocer esos límites condiciona su utilidad pronósticaOur thanks to Maribel Villarino for the help with the development
of the study. L.R.-O. is a Health Professional on Research
Training “Rio Hortega r” (CM13/00131), Ministry of Education,
Government of Spain. R.V.B. is a professional with postdoctoral
contract “Sara Borrell” (CD14/00198) and a project (SAF2014-
60699-JIN) of the Ministry of Economy (MINECO) and FEDER
funds. PI14/00386. PI16/01298. FEDER funds ISCIII-RETIC REDinREN/
RD06/0016, RD12/002
Parathormone levels add prognostic ability to N-terminal pro-brain natriuretic peptide in stable coronary patients
Aims: There are controversial data on the ability of the components of mineral metabolism (vitamin D, phosphate, parathormone [PTH], fibroblast growth factor-23 [FGF23], and klotho) to predict cardiovascular events. In addition, it is unknown whether they add any prognostic value to other well-known biomarkers. Methods and results: In 969 stable coronary patients, we determined plasma levels of all the aforementioned components of mineral metabolism with a complete set of clinical and biochemical variables, including N-terminal pro-brain natriuretic peptide (NT-proBNP), high-sensitivity troponin I (hs-TnI), and high-sensitivity C-reactive protein. Secondary outcomes were ischaemic events (any acute coronary syndrome, stroke, or transient ischaemic attack) and heart failure or death. The primary outcome was a composite of the secondary outcomes. Median follow-up was 5.39 years. Age was 60 (52–72) years. Median glomerular filtration rate was 80.4 (65.3–93.1) mL/min/1.73 m2. One-hundred and eighty-five patients developed the primary outcome. FGF23, PTH, hs-TnI, and NT-proBNP were directly related with the primary outcome on univariate Cox analysis, while Klotho and calcidiol were inversely related. On multivariate analysis, only PTH (HR 1.058 [CI 1.021–1.097]; P = 0.002) and NT-proBNP (HR 1.020 [CI 1.012–1.028]; P 85.5 RU/mL) (P < 0.001) but not in patients with low FGF23 levels (P = 0.551). There was a significant interaction between FGF23 and PTH (P = 0.002). However, there was no significant interaction between PTH and both klotho and calcidiol levels. Conclusions: Parathormone is an independent predictor of cardiovascular events in coronary patients, adding complimentary prognostic information to NT-proBNP plasma levels. This predictive value is restricted to patients with high FGF23 plasma levels. This should be considered in the design of future studies in this field.This work was supported by grants from Instituto de Salud
Carlos III (ISCIII) and Fondos FEDER (Fondo Europeo de
Desarrollo Regional) European Union (PI05/0451, PI14/1567,
PI17/01615, and PI17/01495); Spanish Society of
Cardiology; Spanish Society of Arteriosclerosis; RECAVA (Red
Temática de Investigación Cooperativa en Enfermedades
Cardiovasculares) (RD06/0014/0035); and Instituto de Salud
Carlos III FEDER (FJD biobank: RD09/0076/00101). The
funders had no role in the study design, data collection and
analysis, decision to publish, or preparation of the
manuscript
Search for neutral B meson decays to two charged leptons
The decays are searched for in 3.5 million hadronic events, which constitute the full LEP I data sample collected by the L3 detector. No signals are observed, therefore upper limits at the 90\%(95\%) confidence levels are set on the following branching fractions: % \begin{center}% {\setlength{\tabcolsep}{2pt} \begin{tabular}{lccccclcccc}% % Br & & & & ; & \hspace*{5mm} & Br & & & & ; \\% Br & & & & ; & \hspace*{5mm} & Br & & & & ; \\% Br & & & & ; & \hspace*{5mm} & Br & & & & . \\% % \end{tabular}% } \end{center}% % The results for and are the first limits set on these decay modes
Study of the Weak Charged Hadronic Current in b Decays
Charged and neutral particle multiplicities of jets associated with identified semileptonic and hadronic b decays are studied. The observed differences between these jets are used to determine the inclusive properties of the weak charged hadronic current. The average charged particle multiplicity of the weak charged hadronic current in b decays is measured for the first time to be 2.690.07(stat.)0.14(syst.). This result is in good agreement with the JETSET hadronization model of the weak charged hadronic current if 4017\% of the produced mesons are light--flavored tensor (L=1) mesons. This level of tensor meson production is consistent with the measurement of the multiplicity in the weak charged hadronic current in b decays. \end{abstract
Differences between 2nd and 3rd generation seric parathormone determination methods on mortality in haemodialysis patients
Parathormone plays a key role in controlling mineral metabolism. PTH is considered a uremic toxin causing cardiovascular damage and cardiovascular mortality in dialysis patients. There are two different assays to measure PTH called 2nd generation or intact PTH (iPTH) and 3rd generation or bioPTH (PTHbio).
Objective: To evaluate the differences in mortality of dialysis patients between both assays to measure PTH, as well as the possible prognostic role of the PTHbio/iPTH ratio.
Methods: 145 haemodialysis patients were included with 2-year monitoring including baseline laboratory test and annually thereafter.
Results: 21 patients died in the first year and 28 in the second. No correlation was found between PTH, PTHbio and PTHbio/iPTH ratio with mortality. Both PTH have a perfect correlation between them and correlate similarly with other molecules of the mineral metabolism. The extreme baseline values of PTH are those of higher mortality. In survival by iPTH intervals (according to guidelines and COSMOS study), a J curve is observed. When iPTH increases, the ratio decreases, possibly when increasing fragments no. 1–84. There is no greater prognostic approximation on mortality with PTHbio than PTHi. There was also no difference in mortality when progression ratio PTHbio/PTHi was analysed.
Conclusions: We didn’t find any advantages to using bioPTH vs. PTHi as a marker of mortality. BioPTH limits of normality must be reevaluated because its relationship with iPTH is not consistent. Not knowing these limits affects its prognostic value
Resilience and psychological distress in pregnant women during quarantine due to the COVID-19 outbreak in Spain: a multicentre cross-sectional online survey
Purpose To examine the prevalence of depressive and anxiety symptoms and the corresponding risk factors among pregnant women during the confinement due to the COVID-19 outbreak in Spain. Materials and methods Between 15 April and 14 May 2020, a multicentre cross-sectional survey was performed to study depression, anxiety and resilience in a sample of Spanish pregnant women during the lockdown set up by the Government in response to COVID-19 pandemic outbreak. We designed an anonymous online self-administered questionnaire (https://bit.ly/34RRpq1) that included the Spanish validated versions of the Edinburgh Postpartum Depression Scale (EPDS), the State-Trait Anxiety Inventory (STAI) and the Connor-Davidson Resilience 10-items Scale (CD-RISC-10). Results A total of 514 pregnant women completed the survey. 72.8% had been confined < 40 days and 27.2% between 41 and 60 days. 182 (35.4%) participants scored over 10, with 21.3% scoring over 13 (75th Percentile) in depressive symptoms rates. We found high trait and anxiety scores, with 223 (43.4%) and 227 (44.2%) pregnant women scoring over the trait and state mean scores. Neither depression, anxiety or resilience levels showed any significant correlation with the length of confinement. We found low CD-RISC-10 scores. Conclusions We found a high prevalence of depression and anxiety symptoms during the quarantine, although we did not find an increased prevalence of psychological distress according to length of home confinement. Resilience correlated negatively with depression and anxiety